Market Overview of Global Genitourinary Drugs market:
According to our latest research, the global Genitourinary Drugs market looks promising in the next 5 years. As of 2022, the global Genitourinary Drugs market was estimated at USD 30442.38 million, and it's anticipated to reach USD 32574.96 million in 2028, with a CAGR of 1.13% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Genitourinary Drugs market, with a systematical description of the status quo and trends of the whole market, a close look into the competitive landscape of the major players, and a detailed elaboration on segment markets by type, by application and by region.
Key Takeaways from the Global Genitourinary Drugs Market Report:
Market Size Estimates: Genitourinary Drugs market size estimation in terms of value and sales volume from 2018-2028
Market Trends and Dynamics: Genitourinary Drugs market drivers, opportunities, challenges, and risks
Macro-economy and Regional Conflict: Influence of global inflation and Russia & Ukraine War on the Genitourinary Drugs market
Segment Market Analysis: Genitourinary Drugs market value and sales volume by type and by application from 2018-2028
Regional Market Analysis: Genitourinary Drugs market situations and prospects in North America, Asia Pacific, Europe, Latin America, Middle East, Africa
Country-level Studies on the Genitourinary Drugs Market: Revenue and sales volume of major countries in each region
Genitourinary Drugs Market Competitive Landscape and Major Players: Analysis of 10-15 leading market players, sales, price, revenue, gross, gross margin, product profile and application, etc.
Trade Flow: Import and export volume of the Genitourinary Drugs market in major regions.
Genitourinary Drugs Industry Value Chain: Genitourinary Drugs market raw materials & suppliers, manufacturing process, distributors, downstream customers
Genitourinary Drugs Industry News, Policies & Regulations
Key players in the global Genitourinary Drugs market are covered in Chapter 12:
Immunex Corp.
Bayer AG
Agouron Pharmaceuticals Inc.
Bristol-Myers Squibb Co.
Anturol
Botox
Chiron Inc.
Glaxo Wellcome Plc
Pfizer
Connaught Laboratories Inc.
Hoffman-La Roche Inc.
Abbott Laboratories
Isis Pharmaceuticals
Astellas
Genentech Inc.
GlaxoSmithKline
Eli Lilly
Betanis
Rhone Poulenc Rorer Inc.
Quadra Logic Technologies Inc.
Merck & Co.
Leucomax.
Pharmacia & John Inc
Schering Plough Corp
Merck KGaA
In Chapter 2 and Chapter 15.1, based on types, the Genitourinary Drugs market from 2018 to 2028 is primarily split into:
Sex Hormones
Urologicals
Genitourinary Anti-Infectives
Gynaecologicals
In Chapter 3 and Chapter 15.2, based on applications, the Genitourinary Drugs market from 2018 to 2028 covers:
Genitourinary Cancer
Bladder Cancer
Cervical Cancer
Kidney/Renal Cancer
Ovarian Cancer
Prostate Cancer
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 7, 8, 9, 10, 11, 15.3, 15.4:
North America (Covered in Chapter 7)
United States
Canada
Asia-Pacific (Covered in Chapter 8)
China
Japan
India
South Korea
Southeast Asia
Australia
Others
Europe (Covered in Chapter 9)
Germany
France
UK
Italy
Spain
Russia
Poland
Others
Latin America (Covered in Chapter 10)
Mexico
Brazil
Argentina
Others
Middle East and Africa (Covered in Chapter 11)
GCC Countries
Africa
Others
The data of this research report is mainly obtained from industry associations, magazines, press releases, national customs, annual reports of enterprises, expert interviews, paid databases and other channels with authority. It also provides scientific forecasts of the industry's core development indicators through professional analysis and forecasting models.
In short, whatever role you take in this industry value chain, this report will help you or your company to acquire a systematic and in-depth understanding of the industry.
Chapter Outline
This report consists of 16 chapters. Below is a brief guideline to help you quickly grasp the main contents of each chapter:
Chapter 1 starts the report with an overview of the Genitourinary Drugs market, as well as the definitions of the target market and the subdivisions. Through the presented global market size, regional market sizes, and segment market shares, you will be able to draw an overall and comprehensive picture of the market situation. Meanwhile, the research method and data source will be shared in this chapter.
Chapter 2 and Chapter 3 breaks down the market by different types and applications, with historic data presented in metrics of sales volume, revenue, market share and growth rate.
Chapter 4 elaborates on market dynamics and future trends in the industry, which contains an in-depth analysis of market drivers, opportunities, challenges, and risks. Other essential factors that will have a major impact on the market, i.e., industry news and policies in recent years, global inflation, and regional conflict, are also taken into consideration.
Chapter 5 compares the sales volume and revenue of the major regions across the globe, which enables the readers to understand the regional competitive pattern.
Chapter 6 is the analysis of the trade flow. Import volume and export volume are revealed on a regional level.
Chapters 7-11 focus on country-level studies. Data from the major countries in each region are provided, showing the current development of the industry in different countries. Besides, you will also find qualitative trends analysis under global inflation under each of the 6 regions.
Chapter 12 first up presents the competitive landscape by displaying and comparing the revenues, sales volumes, and market shares of the top players in the market, followed by a company-by-company analysis of all the major market participants with introductions of their products, product applications, company profiles, and business overview. In addition, their competitiveness is manifested through numbers of sales volume, revenue, price, gross and gross margin.
Chapter 13 looks into the whole market industrial chain, ranging from the upstream key raw materials and their suppliers to midstream distributors and downstream customers, with influences of global inflation taken into consideration.
Chapter 14 is perfect for those who wish to develop new projects in the industry. This chapter sheds a light on industry entry barriers and gives suggestions on new project investments.
Chapter 15 forecasts the future trend of the market from the perspective of different types, applications, and major regions.
Chapter 16 is the conclusion of the report which helps the readers sum up the main findings and insights.
Years considered for this report:
Historical Years: 2018-2022
Base Year: 2022
Estimated Year: 2023
Forecast Period: 2023-2028
Global Genitourinary Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Table of Content
1 Genitourinary Drugs Market Overview
1.1 Product Overview
1.2 Market Segmentation
1.2.1 Market by Types
1.2.2 Market by Applications
1.2.3 Market by Regions
1.3 Global Genitourinary Drugs Market Size (2018-2028)
1.3.1 Global Genitourinary Drugs Revenue ($) and Growth Rate (2018-2028)
1.3.2 Global Genitourinary Drugs Sales Volume and Growth Rate (2018-2028)
1.4 Research Method and Logic
1.4.1 Research Method
1.4.2 Research Data Source
2 Global Genitourinary Drugs Market Historic Revenue ($) and Sales Volume Segment by Type
2.1 Global Genitourinary Drugs Historic Revenue ($) by Type (2018-2023)
2.2 Global Genitourinary Drugs Historic Sales Volume by Type (2018-2023)
2.3 Sex Hormones Sales and Price (2018-2023)
2.4 Urologicals Sales and Price (2018-2023)
2.5 Genitourinary Anti-Infectives Sales and Price (2018-2023)
2.6 Gynaecologicals Sales and Price (2018-2023)
3 Global Genitourinary Drugs Historic Revenue ($) and Sales Volume by Application (2018-2023)
3.1 Global Genitourinary Drugs Historic Revenue ($) by Application (2018-2023)
3.2 Global Genitourinary Drugs Historic Sales Volume by Application (2018-2023)
3.3 Genitourinary Cancer Sales, Revenue and Growth Rate (2018-2023)
3.4 Bladder Cancer Sales, Revenue and Growth Rate (2018-2023)
3.5 Cervical Cancer Sales, Revenue and Growth Rate (2018-2023)
3.6 Kidney/Renal Cancer Sales, Revenue and Growth Rate (2018-2023)
3.7 Ovarian Cancer Sales, Revenue and Growth Rate (2018-2023)
3.8 Prostate Cancer Sales, Revenue and Growth Rate (2018-2023)
4 Market Dynamic and Trends
4.1 Industry Development Trends under Global Inflation
4.2 Impact of Russia and Ukraine War
4.3 Driving Factors for Genitourinary Drugs Market
4.4 Factors Challenging the Market
4.5 Opportunities
4.6 Risk Analysis
4.7 Industry News and Policies by Regions
4.7.1 Genitourinary Drugs Industry News
4.7.2 Genitourinary Drugs Industry Policies
5 Global Genitourinary Drugs Market Revenue ($) and Sales Volume by Major Regions
5.1 Global Genitourinary Drugs Sales Volume by Region (2018-2023)
5.2 Global Genitourinary Drugs Market Revenue ($) by Region (2018-2023)
6 Global Genitourinary Drugs Import Volume and Export Volume by Major Regions
6.1 Global Genitourinary Drugs Import Volume by Region (2018-2023)
6.2 Global Genitourinary Drugs Export Volume by Region (2018-2023)
7 North America Genitourinary Drugs Market Current Status (2018-2023)
7.1 Overall Market Size Analysis (2018-2023)
7.1.1 North America Genitourinary Drugs Revenue ($) and Growth Rate (2018-2023)
7.1.2 North America Genitourinary Drugs Sales Volume and Growth Rate (2018-2023)
7.2 North America Genitourinary Drugs Market Trends Analysis Under Global Inflation
7.3 North America Genitourinary Drugs Sales Volume and Revenue ($) by Country (2018-2023)
7.4 United States
7.4.1 United States Genitourinary Drugs Revenue ($) and Growth Rate (2018-2023)
7.5 Canada
7.5.1 Canada Genitourinary Drugs Revenue ($) and Growth Rate (2018-2023)
8 Asia Pacific Genitourinary Drugs Market Current Status (2018-2023)
8.1 Overall Market Size Analysis (2018-2023)
8.1.1 Asia Pacific Genitourinary Drugs Revenue ($) and Growth Rate (2018-2023)
8.1.2 Asia Pacific Genitourinary Drugs Sales Volume and Growth Rate (2018-2023)
8.2 Asia Pacific Genitourinary Drugs Market Trends Analysis Under Global Inflation
8.3 Asia Pacific Genitourinary Drugs Sales Volume and Revenue ($) by Country (2018-2023)
8.4 China
8.4.1 China Genitourinary Drugs Revenue ($) and Growth Rate (2018-2023)
8.5 Japan
8.5.1 Japan Genitourinary Drugs Revenue ($) and Growth Rate (2018-2023)
8.6 India
8.6.1 India Genitourinary Drugs Revenue ($) and Growth Rate (2018-2023)
8.7 South Korea
8.7.1 South Korea Genitourinary Drugs Revenue ($) and Growth Rate (2018-2023)
8.8 Southeast Asia
8.8.1 Southeast Asia Genitourinary Drugs Revenue ($) by Country (2018-2023)
8.9 Australia
8.9.1 Australia Genitourinary Drugs Revenue ($) and Growth Rate (2018-2023)
9 Europe Genitourinary Drugs Market Current Status (2018-2023)
9.1 Overall Market Size Analysis (2018-2023)
9.1.1 Europe Genitourinary Drugs Revenue ($) and Growth Rate (2018-2023)
9.2.1 Europe Genitourinary Drugs Sales Volume and Growth Rate (2018-2023)
9.2 Europe Genitourinary Drugs Market Trends Analysis Under Global Inflation
9.3 Europe Genitourinary Drugs Sales Volume and Revenue ($) by Country (2018-2023)
9.4 Germany
9.4.1 Germany Genitourinary Drugs Revenue ($) and Growth Rate (2018-2023)
9.5 France
9.5.1 France Genitourinary Drugs Revenue ($) and Growth Rate (2018-2023)
9.6 United Kingdom
9.6.1 United Kingdom Genitourinary Drugs Revenue ($) and Growth Rate (2018-2023)
9.7 Italy
9.7.1 Italy Genitourinary Drugs Revenue ($) and Growth Rate (2018-2023)
9.8 Spain
9.8.1 Spain Genitourinary Drugs Revenue ($) and Growth Rate (2018-2023)
9.9 Russia
9.9.1 Russia Genitourinary Drugs Revenue ($) and Growth Rate (2018-2023)
9.10 Poland
9.10.1 Poland Genitourinary Drugs Revenue ($) and Growth Rate (2018-2023)
10 Latin America Genitourinary Drugs Market Current Status (2018-2023)
10.1 Overall Market Size Analysis (2018-2023)
10.1.1 Latin America Genitourinary Drugs Revenue ($) and Growth Rate (2018-2023)
10.1.2 Latin America Genitourinary Drugs Sales Volume and Growth Rate (2018-2023)
10.2 Latin America Genitourinary Drugs Market Trends Analysis Under Global Inflation
10.3 Latin America Genitourinary Drugs Sales Volume and Revenue ($) by Country (2018-2023)
10.4 Mexico
10.4.1 Mexico Genitourinary Drugs Revenue ($) and Growth Rate (2018-2023)
10.5 Brazil
10.5.1 Brazil Genitourinary Drugs Revenue ($) and Growth Rate (2018-2023)
10.6 Argentina
10.6.1 Argentina Genitourinary Drugs Revenue ($) and Growth Rate (2018-2023)
11 Middle East and Africa Genitourinary Drugs Market Current Status (2018-2023)
11.1 Overall Market Size Analysis (2018-2023)
11.1.1 Middle East and Africa Genitourinary Drugs Revenue ($) and Growth Rate (2018-2023)
11.2.1 Middle East and Africa Genitourinary Drugs Sales Volume and Growth Rate (2018-2023)
11.2 Middle East and Africa Genitourinary Drugs Market Trends Analysis Under Global Inflation
11.3 Middle East and Africa Genitourinary Drugs Sales Volume and Revenue ($) by Country (2018-2023)
11.4 GCC Countries
11.4.1 GCC Countries Genitourinary Drugs Revenue ($) and Growth Rate (2018-2023)
11.5 Africa
11.5.1 Africa Genitourinary Drugs Revenue ($) and Growth Rate (2018-2023)
12 Market Competition Analysis and Key Companies Profiles
12.1 Market Competition by Key Players
12.1.1 Global Genitourinary Drugs Revenue ($) and Market Share of Key Players
12.1.2 Global Genitourinary Drugs Sales Volume and Market Share of Key Players
12.1.3 Global Genitourinary Drugs Average Price by Players
12.1.4 Mergers & Acquisitions, Expansion
12.2 Immunex Corp. Market Performance and Business Analysis
12.2.1 Company Profiles
12.2.2 Product Profiles and Application
12.2.3 Immunex Corp. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.3 Bayer AG Market Performance and Business Analysis
12.3.1 Company Profiles
12.3.2 Product Profiles and Application
12.3.3 Bayer AG Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.4 Agouron Pharmaceuticals Inc. Market Performance and Business Analysis
12.4.1 Company Profiles
12.4.2 Product Profiles and Application
12.4.3 Agouron Pharmaceuticals Inc. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.5 Bristol-Myers Squibb Co. Market Performance and Business Analysis
12.5.1 Company Profiles
12.5.2 Product Profiles and Application
12.5.3 Bristol-Myers Squibb Co. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.6 Anturol Market Performance and Business Analysis
12.6.1 Company Profiles
12.6.2 Product Profiles and Application
12.6.3 Anturol Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.7 Botox Market Performance and Business Analysis
12.7.1 Company Profiles
12.7.2 Product Profiles and Application
12.7.3 Botox Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.8 Chiron Inc. Market Performance and Business Analysis
12.8.1 Company Profiles
12.8.2 Product Profiles and Application
12.8.3 Chiron Inc. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.9 Glaxo Wellcome Plc Market Performance and Business Analysis
12.9.1 Company Profiles
12.9.2 Product Profiles and Application
12.9.3 Glaxo Wellcome Plc Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.10 Pfizer Market Performance and Business Analysis
12.10.1 Company Profiles
12.10.2 Product Profiles and Application
12.10.3 Pfizer Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.11 Connaught Laboratories Inc. Market Performance and Business Analysis
12.11.1 Company Profiles
12.11.2 Product Profiles and Application
12.11.3 Connaught Laboratories Inc. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.12 Hoffman-La Roche Inc. Market Performance and Business Analysis
12.12.1 Company Profiles
12.12.2 Product Profiles and Application
12.12.3 Hoffman-La Roche Inc. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.13 Abbott Laboratories Market Performance and Business Analysis
12.13.1 Company Profiles
12.13.2 Product Profiles and Application
12.13.3 Abbott Laboratories Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.14 Isis Pharmaceuticals Market Performance and Business Analysis
12.14.1 Company Profiles
12.14.2 Product Profiles and Application
12.14.3 Isis Pharmaceuticals Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.15 Astellas Market Performance and Business Analysis
12.15.1 Company Profiles
12.15.2 Product Profiles and Application
12.15.3 Astellas Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.16 Genentech Inc. Market Performance and Business Analysis
12.16.1 Company Profiles
12.16.2 Product Profiles and Application
12.16.3 Genentech Inc. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.17 GlaxoSmithKline Market Performance and Business Analysis
12.17.1 Company Profiles
12.17.2 Product Profiles and Application
12.17.3 GlaxoSmithKline Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.18 Eli Lilly Market Performance and Business Analysis
12.18.1 Company Profiles
12.18.2 Product Profiles and Application
12.18.3 Eli Lilly Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.19 Betanis Market Performance and Business Analysis
12.19.1 Company Profiles
12.19.2 Product Profiles and Application
12.19.3 Betanis Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.20 Rhone Poulenc Rorer Inc. Market Performance and Business Analysis
12.20.1 Company Profiles
12.20.2 Product Profiles and Application
12.20.3 Rhone Poulenc Rorer Inc. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.21 Quadra Logic Technologies Inc. Market Performance and Business Analysis
12.21.1 Company Profiles
12.21.2 Product Profiles and Application
12.21.3 Quadra Logic Technologies Inc. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.22 Merck & Co. Market Performance and Business Analysis
12.22.1 Company Profiles
12.22.2 Product Profiles and Application
12.22.3 Merck & Co. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.23 Leucomax. Market Performance and Business Analysis
12.23.1 Company Profiles
12.23.2 Product Profiles and Application
12.23.3 Leucomax. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.24 Pharmacia & John Inc Market Performance and Business Analysis
12.24.1 Company Profiles
12.24.2 Product Profiles and Application
12.24.3 Pharmacia & John Inc Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.25 Schering Plough Corp Market Performance and Business Analysis
12.25.1 Company Profiles
12.25.2 Product Profiles and Application
12.25.3 Schering Plough Corp Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.26 Merck KGaA Market Performance and Business Analysis
12.26.1 Company Profiles
12.26.2 Product Profiles and Application
12.26.3 Merck KGaA Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
13 Value Chain of the Genitourinary Drugs Market
13.1 Value Chain Status
13.1.1 Value Chain Status Under Global Inflation
13.2 Key Raw Materials and Suppliers
13.2.1 Key Raw Materials Introduction
13.2.2 Key Suppliers of Raw Materials
13.3 Manufacturing Cost Structure Analysis
13.3.1 Production Process Analysis
13.3.2 Manufacturing Cost Structure of Genitourinary Drugs
13.3.3 Raw Material Cost of Genitourinary Drugs
13.3.4 Labor Cost of Genitourinary Drugs
13.4 Major Distributors by Region
13.5 Customer Analysis
14 New Project Feasibility Analysis
14.1 Industry Barriers and New Entrants SWOT Analysis
14.2 Analysis and Suggestions on New Project Investment
15 Global Genitourinary Drugs Market Revenue ($) and Sales Volume Forecast Segment by Type, Application and Region
15.1 Global Genitourinary Drugs Revenue ($) and Sales Volume Forecast by Type (2023-2028)
15.1.1 Global Genitourinary Drugs Revenue ($) Forecast by Type (2023-2028)
15.1.2 Global Genitourinary Drugs Sales Volume Forecast by Type (2023-2028)
15.2 Global Genitourinary Drugs Revenue ($) and Sales Volume Forecast by Application (2023-2028)
15.2.1 Global Genitourinary Drugs Revenue ($) Forecast by Application (2023-2028)
15.2.2 Global Genitourinary Drugs Sales Volume Forecast by Application (2023-2028)
15.3 Global Genitourinary Drugs Sales Volume Forecast by Region (2023-2028)
15.4 Global Genitourinary Drugs Revenue ($) Forecast by Region (2023-2028)
16 Research Findings and Conclusion
List of Tables and Figures
Figure Genitourinary Drugs Picture
Table Genitourinary Drugs Definition
Table Description and Definitions
Figure Sex Hormones Features
Figure Urologicals Features
Figure Genitourinary Anti-Infectives Features
Figure Gynaecologicals Features
Table Description and Definitions
Figure Genitourinary Cancer
Figure Bladder Cancer
Figure Cervical Cancer
Figure Kidney/Renal Cancer
Figure Ovarian Cancer
Figure Prostate Cancer
Figure North America Genitourinary Drugs Revenue ($) and Growth Rate (2018-2028)
Figure Asia Pacific Genitourinary Drugs Revenue ($) and Growth Rate (2018-2028)
Figure Europe Genitourinary Drugs Revenue ($) and Growth Rate (2018-2028)
Figure Latin America Genitourinary Drugs Revenue ($) and Growth Rate (2018-2028)
Figure Middle East and Africa Genitourinary Drugs Revenue ($) and Growth Rate (2018-2028)
Figure Global Genitourinary Drugs Revenue ($) and Growth Rate (2018-2028)
Figure Global Genitourinary Drugs Sales Volume and Growth Rate (2018-2028)
Table Global Genitourinary Drugs Historic Revenue ($) by Type (2018-2023) (Million USD)
Table Global Genitourinary Drugs Historic Revenue ($) Share by Type (2018-2023)
Table Global Genitourinary Drugs Historic Sales Volume by Type (2018-2023)
Table Global Genitourinary Drugs Historic Sales Volume Share by Type (2018-2023)
Figure Global Sex Hormones Sales and Growth Rate (2018-2023)
Figure Global Sex Hormones Price (2018-2023)
Figure Global Urologicals Sales and Growth Rate (2018-2023)
Figure Global Urologicals Price (2018-2023)
Figure Global Genitourinary Anti-Infectives Sales and Growth Rate (2018-2023)
Figure Global Genitourinary Anti-Infectives Price (2018-2023)
Figure Global Gynaecologicals Sales and Growth Rate (2018-2023)
Figure Global Gynaecologicals Price (2018-2023)
Table Global Genitourinary Drugs Historic Revenue ($) by Application (2018-2023) (Million USD)
Table Global Genitourinary Drugs Historic Revenue ($) Share by Application (2018-2023)
Table Global Genitourinary Drugs Historic Sales Volume by Application (2018-2023) (Million USD)
Table Global Genitourinary Drugs Historic Sales Volume Share by Application (2018-2023)
Figure Global Genitourinary Cancer Sales and Growth Rate (2018-2023)
Figure Global Genitourinary Cancer Revenue and Growth Rate (2018-2023)
Figure Global Bladder Cancer Sales and Growth Rate (2018-2023)
Figure Global Bladder Cancer Revenue and Growth Rate (2018-2023)
Figure Global Cervical Cancer Sales and Growth Rate (2018-2023)
Figure Global Cervical Cancer Revenue and Growth Rate (2018-2023)
Figure Global Kidney/Renal Cancer Sales and Growth Rate (2018-2023)
Figure Global Kidney/Renal Cancer Revenue and Growth Rate (2018-2023)
Figure Global Ovarian Cancer Sales and Growth Rate (2018-2023)
Figure Global Ovarian Cancer Revenue and Growth Rate (2018-2023)
Figure Global Prostate Cancer Sales and Growth Rate (2018-2023)
Figure Global Prostate Cancer Revenue and Growth Rate (2018-2023)
Table Industry Development Trends under Global Inflation
Table Impact of Russia and Ukraine War
Table Driving Factors for Genitourinary Drugs Market
Table Factors Challenging the Market
Table Opportunities
Table Risk Analysis
Table Industry News by Regions
Table Industry Policies by Regions
Table Global Genitourinary Drugs Sales Volume by Region (2018-2023)
Table Global Genitourinary Drugs Sales Volume Share by Region (2018-2023)
Table Global Genitourinary Drugs Market Revenue ($) by Region (2018-2023)
Table Global Genitourinary Drugs Market Revenue ($) Share by Region (2018-2023)
Table Global Genitourinary Drugs Import Volume by Region (2018-2023)
Table Global Genitourinary Drugs Export Volume by Region (2018-2023)
Figure North America Genitourinary Drugs Revenue ($) and Growth Rate (2018-2023)
Figure North America Genitourinary Drugs Sales Volume and Growth Rate (2018-2023)
Table North America Genitourinary Drugs Market Trends Analysis Under Global Inflation
Table North America Genitourinary Drugs Revenue ($) by Country (2018-2023)
Table North America Genitourinary Drugs Sales Volume by Country (2018-2023)
Figure United States Genitourinary Drugs Revenue ($) and Growth Rate (2018-2023)
Figure Canada Genitourinary Drugs Revenue ($) and Growth Rate (2018-2023)
Figure Asia Pacific Genitourinary Drugs Revenue ($) and Growth Rate (2018-2023)
Figure Asia Pacific Genitourinary Drugs Sales Volume and Growth Rate (2018-2023)
Table Asia Pacific Genitourinary Drugs Market Trends Analysis Under Global Inflation
Table Asia Pacific Genitourinary Drugs Revenue ($) by Country (2018-2023)
Table Asia Pacific Genitourinary Drugs Sales Volume by Country (2018-2023)
Figure China Genitourinary Drugs Revenue ($) and Growth Rate (2018-2023)
Figure Japan Genitourinary Drugs Revenue ($) and Growth Rate (2018-2023)
Figure India Genitourinary Drugs Revenue ($) and Growth Rate (2018-2023)
Figure South Korea Genitourinary Drugs Revenue ($) and Growth Rate (2018-2023)
Table Southeast Asia Genitourinary Drugs Revenue ($) by Country (2018-2023)
Figure Australia Genitourinary Drugs Revenue ($) and Growth Rate (2018-2023)
Figure Europe Genitourinary Drugs Revenue ($) and Growth Rate (2018-2023)
Figure Europe Genitourinary Drugs Sales Volume and Growth Rate (2018-2023)
Table Europe Genitourinary Drugs Market Trends Analysis Under Global Inflation
Table Europe Genitourinary Drugs Revenue ($) by Country (2018-2023)
Table Europe Genitourinary Drugs Sales Volume by Country (2018-2023)
Figure Germany Genitourinary Drugs Revenue ($) and Growth Rate (2018-2023)
Figure France Genitourinary Drugs Revenue ($) and Growth Rate (2018-2023)
Figure United Kingdom Genitourinary Drugs Revenue ($) and Growth Rate (2018-2023)
Figure Italy Genitourinary Drugs Revenue ($) and Growth Rate (2018-2023)
Figure Spain Genitourinary Drugs Revenue ($) and Growth Rate (2018-2023)
Figure Russia Genitourinary Drugs Revenue ($) and Growth Rate (2018-2023)
Figure Poland Genitourinary Drugs Revenue ($) and Growth Rate (2018-2023)
Figure Latin America Genitourinary Drugs Revenue ($) and Growth Rate (2018-2023)
Figure Latin America Genitourinary Drugs Sales Volume and Growth Rate (2018-2023)
Table Latin America Genitourinary Drugs Market Trends Analysis Under Global Inflation
Table Latin America Genitourinary Drugs Revenue ($) by Country (2018-2023)
Table Latin America Genitourinary Drugs Sales Volume by Country (2018-2023)
Figure Mexico Genitourinary Drugs Revenue ($) and Growth Rate (2018-2023)
Figure Brazil Genitourinary Drugs Revenue ($) and Growth Rate (2018-2023)
Figure Argentina Genitourinary Drugs Revenue ($) and Growth Rate (2018-2023)
Figure Middle East and Africa Genitourinary Drugs Revenue ($) and Growth Rate (2018-2023)
Figure Middle East and Africa Genitourinary Drugs Sales Volume and Growth Rate (2018-2023)
Table Middle East and Africa Genitourinary Drugs Market Trends Analysis Under Global Inflation
Table Middle East and Africa Genitourinary Drugs Revenue ($) by Country (2018-2023)
Table Middle East and Africa Genitourinary Drugs Sales Volume by Country (2018-2023)
Figure GCC Countries Genitourinary Drugs Revenue ($) and Growth Rate (2018-2023)
Figure Africa Genitourinary Drugs Revenue ($) and Growth Rate (2018-2023)
Table Global Genitourinary Drugs Revenue ($) of Key Players (2018-2023)
Table Global Genitourinary Drugs Revenue ($) Share of Key Players (2018-2023)
Table Global Genitourinary Drugs Sales Volume of Key Players (2018-2023)
Table Global Genitourinary Drugs Sales Volume Share of Key Players (2018-2023)
Table Global Genitourinary Drugs Average Price of Key Players (2018-2023)
Table Mergers & Acquisitions, Expansion Plans
Table Immunex Corp. Company Profiles
Table Product Profiles and Application
Table Immunex Corp. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Immunex Corp. Production and Growth Rate
Figure Immunex Corp. Value ($) Market Share 2018-2023
Table Bayer AG Company Profiles
Table Product Profiles and Application
Table Bayer AG Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Bayer AG Production and Growth Rate
Figure Bayer AG Value ($) Market Share 2018-2023
Table Agouron Pharmaceuticals Inc. Company Profiles
Table Product Profiles and Application
Table Agouron Pharmaceuticals Inc. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Agouron Pharmaceuticals Inc. Production and Growth Rate
Figure Agouron Pharmaceuticals Inc. Value ($) Market Share 2018-2023
Table Bristol-Myers Squibb Co. Company Profiles
Table Product Profiles and Application
Table Bristol-Myers Squibb Co. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Bristol-Myers Squibb Co. Production and Growth Rate
Figure Bristol-Myers Squibb Co. Value ($) Market Share 2018-2023
Table Anturol Company Profiles
Table Product Profiles and Application
Table Anturol Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Anturol Production and Growth Rate
Figure Anturol Value ($) Market Share 2018-2023
Table Botox Company Profiles
Table Product Profiles and Application
Table Botox Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Botox Production and Growth Rate
Figure Botox Value ($) Market Share 2018-2023
Table Chiron Inc. Company Profiles
Table Product Profiles and Application
Table Chiron Inc. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Chiron Inc. Production and Growth Rate
Figure Chiron Inc. Value ($) Market Share 2018-2023
Table Glaxo Wellcome Plc Company Profiles
Table Product Profiles and Application
Table Glaxo Wellcome Plc Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Glaxo Wellcome Plc Production and Growth Rate
Figure Glaxo Wellcome Plc Value ($) Market Share 2018-2023
Table Pfizer Company Profiles
Table Product Profiles and Application
Table Pfizer Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Pfizer Production and Growth Rate
Figure Pfizer Value ($) Market Share 2018-2023
Table Connaught Laboratories Inc. Company Profiles
Table Product Profiles and Application
Table Connaught Laboratories Inc. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Connaught Laboratories Inc. Production and Growth Rate
Figure Connaught Laboratories Inc. Value ($) Market Share 2018-2023
Table Hoffman-La Roche Inc. Company Profiles
Table Product Profiles and Application
Table Hoffman-La Roche Inc. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Hoffman-La Roche Inc. Production and Growth Rate
Figure Hoffman-La Roche Inc. Value ($) Market Share 2018-2023
Table Abbott Laboratories Company Profiles
Table Product Profiles and Application
Table Abbott Laboratories Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Abbott Laboratories Production and Growth Rate
Figure Abbott Laboratories Value ($) Market Share 2018-2023
Table Isis Pharmaceuticals Company Profiles
Table Product Profiles and Application
Table Isis Pharmaceuticals Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Isis Pharmaceuticals Production and Growth Rate
Figure Isis Pharmaceuticals Value ($) Market Share 2018-2023
Table Astellas Company Profiles
Table Product Profiles and Application
Table Astellas Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Astellas Production and Growth Rate
Figure Astellas Value ($) Market Share 2018-2023
Table Genentech Inc. Company Profiles
Table Product Profiles and Application
Table Genentech Inc. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Genentech Inc. Production and Growth Rate
Figure Genentech Inc. Value ($) Market Share 2018-2023
Table GlaxoSmithKline Company Profiles
Table Product Profiles and Application
Table GlaxoSmithKline Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure GlaxoSmithKline Production and Growth Rate
Figure GlaxoSmithKline Value ($) Market Share 2018-2023
Table Eli Lilly Company Profiles
Table Product Profiles and Application
Table Eli Lilly Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Eli Lilly Production and Growth Rate
Figure Eli Lilly Value ($) Market Share 2018-2023
Table Betanis Company Profiles
Table Product Profiles and Application
Table Betanis Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Betanis Production and Growth Rate
Figure Betanis Value ($) Market Share 2018-2023
Table Rhone Poulenc Rorer Inc. Company Profiles
Table Product Profiles and Application
Table Rhone Poulenc Rorer Inc. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Rhone Poulenc Rorer Inc. Production and Growth Rate
Figure Rhone Poulenc Rorer Inc. Value ($) Market Share 2018-2023
Table Quadra Logic Technologies Inc. Company Profiles
Table Product Profiles and Application
Table Quadra Logic Technologies Inc. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Quadra Logic Technologies Inc. Production and Growth Rate
Figure Quadra Logic Technologies Inc. Value ($) Market Share 2018-2023
Table Merck & Co. Company Profiles
Table Product Profiles and Application
Table Merck & Co. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Merck & Co. Production and Growth Rate
Figure Merck & Co. Value ($) Market Share 2018-2023
Table Leucomax. Company Profiles
Table Product Profiles and Application
Table Leucomax. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Leucomax. Production and Growth Rate
Figure Leucomax. Value ($) Market Share 2018-2023
Table Pharmacia & John Inc Company Profiles
Table Product Profiles and Application
Table Pharmacia & John Inc Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Pharmacia & John Inc Production and Growth Rate
Figure Pharmacia & John Inc Value ($) Market Share 2018-2023
Table Schering Plough Corp Company Profiles
Table Product Profiles and Application
Table Schering Plough Corp Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Schering Plough Corp Production and Growth Rate
Figure Schering Plough Corp Value ($) Market Share 2018-2023
Table Merck KGaA Company Profiles
Table Product Profiles and Application
Table Merck KGaA Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Merck KGaA Production and Growth Rate
Figure Merck KGaA Value ($) Market Share 2018-2023
Figure Industry Chain Analysis of Genitourinary Drugs
Table Value Chain Status Under Global Inflation
Table Key Raw Materials Introduction
Table Upstream Raw Material Suppliers of Genitourinary Drugs with Contact Information
Figure Production Process of Genitourinary Drugs
Figure Manufacturing Cost Structure of Genitourinary Drugs
Table Major Distributors of Genitourinary Drugs with Contact Information
Table Major Downstream Buyers of Genitourinary Drugs with Contact Information
Figure Industry Resource/Technology/Labor Importance Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery
Table Global Genitourinary Drugs Revenue ($) Forecast by Type (2023-2028) (Million USD)
Table Global Genitourinary Drugs Revenue ($) Share Forecast by Type (2023-2028)
Table Global Genitourinary Drugs Sales Volume Forecast by Type (2023-2028) (Million USD)
Table Global Genitourinary Drugs Sales Volume Share Forecast by Type (2023-2028)
Table Global Genitourinary Drugs Revenue ($) Forecast by Application (2023-2028) (Million USD)
Table Global Genitourinary Drugs Revenue ($) Share Forecast by Application (2023-2028)
Table Global Genitourinary Drugs Sales Volume Forecast by Application (2023-2028) (Million USD)
Table Global Genitourinary Drugs Sales Volume Share Forecast by Application (2023-2028)
Table Global Genitourinary Drugs Sales Volume Forecast by Region (2023-2028)
Table Global Genitourinary Drugs Sales Volume Share Forecast by Region (2023-2028)
Table Global Genitourinary Drugs Revenue ($) Forecast by Region (2023-2028)
Table Global Genitourinary Drugs Revenue ($) Share Forecast by Region (2023-2028)
Global Overactive Bladder Treatment Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 93
According to our LPI (LP Information) latest study, the global Overactive Bladder Treatment market size was valued at US$ 4989.1 million in 2023. With growing demand in downstream market, the Overactive Bladder Treatment is forecast to a readjusted size of US$ 6182.8 million by 2030 with a CAGR of 3.1% during review period.
The research report highlights the growth potential of the global Overactive Bladder Treatment market. Overactive Bladder Treatment are expected to show stable growth......
Global Genitourinary Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 02-Jan-2024 Price: US 3380 Onwards Pages: 110
Market Overview of Global Genitourinary Drugs market:
According to our latest research, the global Genitourinary Drugs market looks promising in the next 5 years. As of 2022, the global Genitourinary Drugs market was estimated at USD 30442.38 million, and it's anticipated to reach USD 32574.96 million in 2028, with a CAGR of 1.13% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global ......
Global Urinary Tract Infection Treatment Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 21-Dec-2023 Price: US 3380 Onwards Pages: 100
Market Overview of Global Urinary Tract Infection Treatment market:
According to our latest research, the global Urinary Tract Infection Treatment market looks promising in the next 5 years. As of 2022, the global Urinary Tract Infection Treatment market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
A urinary tract infection is an infection that can occur in any area of the urinary tract, i......
Global Overactive Bladder Treatment Market Research Report 2023, Forecast to 2028
Published: 02-Nov-2023 Price: US 2680 Onwards Pages: 130
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period.
D......
Global Overactive Bladder Treatment Professional Survey Report 2023, Forecast to 2028
Published: 02-Nov-2023 Price: US 3280 Onwards Pages: 103
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period.
D......
Global Overactive Bladder Treatment Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 17-Oct-2023 Price: US 3380 Onwards Pages: 105
Market Overview of Global Overactive Bladder Treatment market:
According to our latest research, the global Overactive Bladder Treatment market looks promising in the next 5 years. As of 2022, the global Overactive Bladder Treatment market was estimated at USD 3983.87 million, and it's anticipated to reach USD 5304.63 million in 2028, with a CAGR of 4.89% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensiv......
Genitourinary Collaboration and Licensing Deals 2016-2023
Published: 01-Oct-2023 Price: US 3995 Onwards Pages: 150
Genitourinary Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the genitourinary deals entered into by the worlds leading biopharma companies.
Fully revised and updated, the report provides details of genitourinary deals from 2016 to 2023.
The report provides access to deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms.
Underst......
Global Genitourinary Drugs Market Insights, Forecast to 2029
Published: 14-Aug-2023 Price: US 4900 Onwards Pages: 70
The global Genitourinary Drugs market is projected to grow from US$ 29570 million in 2023 to US$ 35930 million by 2029, at a Compound Annual Growth Rate (CAGR) of 3.3% during the forecast period.
The US & Canada market for Genitourinary Drugs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Genitourinary Drugs is estimated to increase from $ million in 202......
Global Overactive Bladder Therapeutics Market Insights, Forecast to 2029
Published: 28-Jun-2023 Price: US 4900 Onwards Pages: 88
Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control). This report only focuses on the treatment drugs and Device.
Market Analysis and Insights: Global Overactive Bladder Therapeutics Market
The global Overactive Bladder Therapeutics market is projected to grow from US$ 5240.8 million in 2023 t......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
